Literature DB >> 15569761

Reversible white matter lesion in methionine adenosyltransferase I/III deficiency.

Hiroko Tada1, Jun-ichi Takanashi, A James Barkovich, Shigenori Yamamoto, Yoichi Kohno.   

Abstract

A 5-year-old boy with methionine adenosyltransferase (MAT) I/III deficiency, under treatment for the tentative diagnosis of homocystinuria, presented with mildly decreased appetite and sleepiness. MR imaging showed abnormal T1 and T2 prolongations and reduced diffusion in the cerebral white matter. Clinical symptoms and MR imaging findings improved after discontinuation of therapy. We speculate that inappropriate treatment might enhance CNS lesions of MAT I/III deficiency by causing a reversible vacuolating myelinopathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15569761      PMCID: PMC8148727     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  9 in total

1.  Diffusion-weighted MR imaging in the brain in children: findings in the normal brain and in the brain with white matter diseases.

Authors:  Volkher Engelbrecht; Axel Scherer; Margarethe Rassek; Hans J Witsack; Ulrich Mödder
Journal:  Radiology       Date:  2002-02       Impact factor: 11.105

2.  A new leukoencephalopathy with vanishing white matter.

Authors:  M S van der Knaap; P G Barth; F J Gabreëls; E Franzoni; J H Begeer; H Stroink; J J Rotteveel; J Valk
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

3.  Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria.

Authors:  M D Phillips; P McGraw; M J Lowe; V P Mathews; B E Hainline
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

4.  Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway.

Authors:  R Surtees; J Leonard; S Austin
Journal:  Lancet       Date:  1991 Dec 21-28       Impact factor: 79.321

5.  Methionine adenosyltransferase I/III deficiency: novel mutations and clinical variations.

Authors:  M E Chamberlin; T Ubagai; S H Mudd; J Thomas; V Y Pao; T K Nguyen; H L Levy; C Greene; C Freehauf; J Y Chou
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

6.  Distal motor axonopathy and central nervous system myelin vacuolation caused by cycloleucine, an inhibitor of methionine adenosyltransferase.

Authors:  C C Lee; R Surtees; L W Duchen
Journal:  Brain       Date:  1992-06       Impact factor: 13.501

7.  Elevated plasma total homocysteine in severe methionine adenosyltransferase I/III deficiency.

Authors:  Sally P Stabler; Clemens Steegborn; Markus C Wahl; Jana Oliveriusova; Jan P Kraus; Robert H Allen; Conrad Wagner; S Harvey Mudd
Journal:  Metabolism       Date:  2002-08       Impact factor: 8.694

8.  Diffusion-weighted MR imaging in neonatal nonketotic hyperglycinemia.

Authors:  Pek-Lan Khong; Barbara C C Lam; Brian H Y Chung; Ka-Yin Wong; Gaik-Cheng Ooi
Journal:  AJNR Am J Neuroradiol       Date:  2003 Jun-Jul       Impact factor: 3.825

9.  Biochemical analysis of myelin lipids and proteins in a model of methyl donor pathway deficit: effect of S-adenosylmethionine.

Authors:  R Bianchi; F Calzi; S Savaresi; R Sciarretta-Birolo; R Bellasio; V Tsankova; M T Tacconi
Journal:  Exp Neurol       Date:  1999-09       Impact factor: 5.330

  9 in total
  17 in total

1.  T2 hyperintense signal of the central tegmental tracts in children: disease or normal maturational process?

Authors:  Sergio Aguilera-Albesa; Andrea Poretti; Dagmar Honnef; Meral Aktas; Maria Eugenia Yoldi-Petri; Thierry A G M Huisman; Martin Häusler
Journal:  Neuroradiology       Date:  2012-01-21       Impact factor: 2.804

2.  Characteristic MR imaging changes in severe hypermethioninemic states.

Authors:  Nancy E Braverman; S Harvey Mudd; Peter B Barker; Martin G Pomper
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

3.  Central tegmental tract involvement in an infant with 6-pyruvoyltetrahydropterin synthetase deficiency.

Authors:  J Takanashi; M Kanazawa; Y Kohno
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

4.  Brainstem tegmental lesions in neonates with hypoxic-ischemic encephalopathy: Magnetic resonance diagnosis and clinical outcome.

Authors:  Carlo Cosimo Quattrocchi; Giuseppe Fariello; Daniela Longo
Journal:  World J Radiol       Date:  2016-02-28

5.  Brain Magnetic Resonance Imaging Findings in Poorly Controlled Homocystinuria.

Authors:  Charles Q Li; Bruce A Barshop; Annette Feigenbaum; Paritosh C Khanna
Journal:  J Radiol Case Rep       Date:  2018-01-31

6.  MRI and (1)H-MRS in adenosine kinase deficiency.

Authors:  C Staufner; H J Blom; C Dionisi-Vici; P Freisinger; N Makhseed; D Ballhausen; S Kölker; G F Hoffmann; I Harting
Journal:  Neuroradiology       Date:  2016-03-18       Impact factor: 2.804

7.  Symmetrical central tegmental tract (CTT) hyperintense lesions on magnetic resonance imaging in children.

Authors:  Shoko Yoshida; Katsumi Hayakawa; Akira Yamamoto; Noriko Aida; Souzo Okano; Hiroko Matsushita; Toyoko Kanda; Yuriko Yamori; Naoko Yoshida; Haruyo Hirota
Journal:  Eur Radiol       Date:  2008-09-16       Impact factor: 5.315

8.  Determination of Autosomal Dominant or Recessive Methionine Adenosyltransferase I/III Deficiencies Based on Clinical and Molecular Studies.

Authors:  Yoo-Mi Kim; Ja Hye Kim; Jin Choi; Kim Gu-Hwan; Jae-Min Kim; Minji Kang; In-Hee Choi; Chong Kun Cheon; Young Bae Sohn; Marco Maccarana; Han-Wook Yoo; Beom Hee Lee
Journal:  Mol Med       Date:  2016-02-18       Impact factor: 6.354

9.  Hypermethioninaemia due to methionine adenosyltransferase I/III (MAT I/III) deficiency: diagnosis in an expanded neonatal screening programme.

Authors:  M L Couce; M D Bóveda; D E Castiñeiras; F J Corrales; M I Mora; J M Fraga; S H Mudd
Journal:  J Inherit Metab Dis       Date:  2008-05-20       Impact factor: 4.982

Review 10.  Inherited disorders in the conversion of methionine to homocysteine.

Authors:  Ivo Barić
Journal:  J Inherit Metab Dis       Date:  2009-07-07       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.